共 50 条
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
被引:15
作者:
Rieken, M.
[1
,2
]
Kluth, L. A.
[1
,3
]
Xylinas, E.
[1
,4
]
Seitz, C.
[5
]
Fajkovic, H.
[5
]
Karakiewicz, P. I.
[6
]
Lotan, Y.
[7
]
Briganti, A.
[8
]
Loidl, W.
[9
]
Faison, T.
[1
]
Crivelli, J. J.
[1
]
Scherr, D. S.
[1
]
Bachmann, A.
[2
]
Tewari, A. K.
[1
]
Kautzky-Willer, A.
[10
]
Pummer, K.
[11
]
Shariat, S. F.
[1
,5
]
机构:
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Urol, New York, NY USA
[2] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland
[3] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[4] Univ Paris 05, Cochin Hosp, AP HP, Dept Urol, Paris, France
[5] Med Univ Vienna, Dept Urol, A-1090 Vienna, Austria
[6] Univ Montreal, Dept Urol, Montreal, PQ, Canada
[7] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[8] Ist Sci San Raffaele, Urol Res Inst, Dept Urol, I-20132 Milan, Italy
[9] Hosp Barmherzige Schwestern Linz, Prostate Canc Ctr, Linz, Austria
[10] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Unit Gender Med, A-1090 Vienna, Austria
[11] Med Univ Graz, Dept Urol, Graz, Austria
基金:
瑞士国家科学基金会;
关键词:
statins;
radical prostatectomy;
biochemical recurrence;
HOSPITAL SEARCH DATABASE;
CANCER RECURRENCE;
RADIATION-THERAPY;
METAANALYSIS;
OUTCOMES;
RADIOTHERAPY;
CHOLESTEROL;
RISK;
MEN;
D O I:
10.1038/pcan.2013.31
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
BACKGROUND: The impact of statin use on biochemical recurrence (BCR) in patients treated with radical prostatectomy (RP) remains controversial. METHODS: We retrospectively evaluated 6842 patients who underwent RP for clinically localized prostate cancer (PC) between 2000 and 2011. Uni- and multivariable cox regression models addressed the association of statin use with BCR. RESULTS: Overall, 2275 (33.3%) patients used statins. Statin users were older and had a higher rate of positive surgical margins than patients not using statins (P-values <= 0.05). Within a median follow-up of 25 months (interquartile range: 8-42 months), 778 (11.4%) patients experienced BCR. Actuarial estimate 5-years BCR-free survival was 82% +/- 1 for patients without statin use and 84 +/- 1% for patients using statins (P = 0.05); statin use was not associated with BCR (hazard ratio: 0.88, 95% confidence interval: 0.76-1.03, P = 0.10) after adjusting for the effects of standard clinicopathologic features. CONCLUSIONS: In PC patients undergoing RP, statin use was not independently associated with lower risk of BCR.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 50 条